Literature DB >> 27709491

P2X3 and P2X2/3 Receptors Play a Crucial Role in Articular Hyperalgesia Development Through Inflammatory Mechanisms in the Knee Joint Experimental Synovitis.

Juliana Maia Teixeira1, Franciane Bobinski2, Carlos Amílcar Parada1, Kathleen A Sluka3, Cláudia Herrera Tambeli4.   

Abstract

Osteoarthritis (OA) is a degenerative and progressive disease characterized by cartilage breakdown and by synovial membrane inflammation, which results in disability, joint swelling, and pain. The purinergic P2X3 and P2X2/3 receptors contribute to development of inflammatory hyperalgesia, participate in arthritis processes in the knee joint, and are expressed in chondrocytes and nociceptive afferent fibers innervating the knee joint. In this study, we hypothesized that P2X3 and P2X2/3 receptors activation by endogenous ATP (adenosine 5'-triphosphate) induces articular hyperalgesia in the knee joint of male and female rats through an indirect sensitization of primary afferent nociceptors dependent on the previous release of pro-inflammatory cytokines and/or on neutrophil migration. We found that the blockade of articular P2X3 and P2X2/3 receptors significantly attenuated carrageenan-induced hyperalgesia in the knee joint of male and estrus female rats in a similar manner. The carrageenan-induced knee joint inflammation increased the expression of P2X3 receptors in chondrocytes of articular cartilage. Further, the blockade of articular P2X3 and P2X2/3 receptors significantly reduced the increased concentration of TNF-α, IL-6, and CINC-1 and the neutrophil migration induced by carrageenan. These findings indicate that P2X3 and P2X2/3 receptors activation by endogenous ATP is essential to hyperalgesia development in the knee joint through an indirect sensitization of primary afferent nociceptors dependent on the previous release of pro-inflammatory cytokines and/or on neutrophil migration.

Entities:  

Keywords:  Articular hyperalgesia; Chondrocytes; Knee joint; Neutrophil migration; P2X3 and P2X2/3 receptors; Pro-inflammatory cytokines

Mesh:

Substances:

Year:  2016        PMID: 27709491      PMCID: PMC5380594          DOI: 10.1007/s12035-016-0146-2

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  84 in total

1.  Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

Authors:  P E Lipsky; D M van der Heijde; E W St Clair; D E Furst; F C Breedveld; J R Kalden; J S Smolen; M Weisman; P Emery; M Feldmann; G R Harriman; R N Maini
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

2.  The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy.

Authors:  M S Smith; M E Freeman; J D Neill
Journal:  Endocrinology       Date:  1975-01       Impact factor: 4.736

3.  Characterization of multiple P2X receptors in cultured normal human epidermal keratinocytes.

Authors:  Kaori Inoue; Mitsuhiro Denda; Hidetoshi Tozaki; Kayoko Fujishita; Schuichi Koizumi; Kazuhide Inoue
Journal:  J Invest Dermatol       Date:  2005-04       Impact factor: 8.551

4.  Carrageenin-induced arthritis. I. The effect of intraarticular carrageenin on the chemical composition of articular cartilage.

Authors:  D A Lowther; G C Gillard
Journal:  Arthritis Rheum       Date:  1976 Jul-Aug

5.  Correlation of changes in pain intensity with synovial fluid adenosine triphosphate levels after treatment of patients with osteoarthritis of the knee with high-molecular-weight hyaluronic acid.

Authors:  Nobuyuki Kumahashi; Kohei Naitou; Hideyuki Nishi; Kazunori Oae; Yohei Watanabe; Suguru Kuwata; Mitsuo Ochi; Mitsugu Ikeda; Yuji Uchio
Journal:  Knee       Date:  2010-06-03       Impact factor: 2.199

6.  Effect of interleukin-6 receptor inhibitor, tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF inhibitors.

Authors:  Yoshiya Tanaka; Tsutomu Takeuchi; Koichi Amano; Kazuyoshi Saito; Kentaro Hanami; Masao Nawata; Shunsuke Fukuyo; Hideto Kameda; Yuko Kaneko; Takahiko Kurasawa; Hayato Nagasawa; Daisuke Hoshi; Eri Sato; Hisashi Yamanaka
Journal:  Mod Rheumatol       Date:  2013-11-05       Impact factor: 3.023

7.  In vivo leukocyte migration in arthritis.

Authors:  A K Jones; M A al-Janabi; K Solanki; R Sobnack; A Greenwood; D V Doyle; K E Britton; E C Huskisson
Journal:  Arthritis Rheum       Date:  1991-03

8.  Interleukin-8 as a mediator of sympathetic pain.

Authors:  F Q Cunha; B B Lorenzetti; S Poole; S H Ferreira
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

9.  Cytokine-induced neutrophil chemoattractant 1 (CINC-1) mediates the sympathetic component of inflammatory mechanical hypersensitivitiy in rats.

Authors:  Berenice B Lorenzetti; Fabiane H Veiga; Claudio A Canetti; Stephen Poole; Fernando Q Cunha; Sérgio H Ferreira
Journal:  Eur Cytokine Netw       Date:  2002 Oct-Dec       Impact factor: 2.737

10.  TNFalpha mechanically sensitizes masseter muscle afferent fibers of male rats.

Authors:  Akhlaq W Hakim; Xu-Dong Dong; Peter Svensson; Ujendra Kumar; Brian E Cairns
Journal:  J Neurophysiol       Date:  2009-06-24       Impact factor: 2.714

View more
  15 in total

1.  Action of MK-7264 (gefapixant) at human P2X3 and P2X2/3 receptors and in vivo efficacy in models of sensitisation.

Authors:  David Richards; Joel R Gever; Anthony P Ford; Samuel J Fountain
Journal:  Br J Pharmacol       Date:  2019-05-11       Impact factor: 8.739

2.  P2X3 receptors contribute to transition from acute to chronic muscle pain.

Authors:  Carolina Ocanha Jorge; Graciana de Azambuja; Beatriz Botasso Gomes; Hayla Lourenço Rodrigues; Augusto Ducati Luchessi; Maria Cláudia Gonçalves de Oliveira-Fusaro
Journal:  Purinergic Signal       Date:  2020-08-06       Impact factor: 3.765

Review 3.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

Review 4.  Inflammation in osteoarthritis: is it time to dampen the alarm(in) in this debilitating disease?

Authors:  M H J van den Bosch
Journal:  Clin Exp Immunol       Date:  2018-11-28       Impact factor: 4.330

5.  The citrus flavanone naringenin attenuates zymosan-induced mouse joint inflammation: induction of Nrf2 expression in recruited CD45+ hematopoietic cells.

Authors:  Allan J C Bussmann; Sergio M Borghi; Tiago H Zaninelli; Telma S Dos Santos; Carla F S Guazelli; Victor Fattori; Talita P Domiciano; Felipe A Pinho-Ribeiro; Kenji W Ruiz-Miyazawa; Antonio M B Casella; Josiane A Vignoli; Doumit Camilios-Neto; Rubia Casagrande; Waldiceu A Verri
Journal:  Inflammopharmacology       Date:  2019-01-05       Impact factor: 4.473

6.  Enhancement of P2X3 Receptor-Mediated Currents by Lysophosphatidic Acid in Rat Primary Sensory Neurons.

Authors:  Wen-Long Qiao; Qing Li; Jia-Wei Hao; Shuang Wei; Xue-Mei Li; Ting-Ting Liu; Chun-Yu Qiu; Wang-Ping Hu
Journal:  Front Pharmacol       Date:  2022-06-20       Impact factor: 5.988

7.  A cyclic pathway of P2 × 7, bradykinin, and dopamine receptor activation induces a sustained articular hyperalgesia in the knee joint of rats.

Authors:  Juliana Maia Teixeira; Carlos Amílcar Parada; Cláudia Herrera Tambeli
Journal:  Inflamm Res       Date:  2017-12-19       Impact factor: 4.575

8.  P2X4 Receptors on Muscle Macrophages Are Required for Development of Hyperalgesia in an Animal Model of Activity-Induced Muscle Pain.

Authors:  Maria Claudia Oliveira-Fusaro; Nicholas S Gregory; Sandra J Kolker; Lynn Rasmussen; Lee-Ann H Allen; Kathleen A Sluka
Journal:  Mol Neurobiol       Date:  2020-01-02       Impact factor: 5.590

9.  The interaction between P2X3 and TRPV1 in the dorsal root ganglia of adult rats with different pathological pains.

Authors:  Jie Yu; Junying Du; Junfan Fang; Yingjun Liu; Xuaner Xiang; Yi Liang; Xiaomei Shao; Jianqiao Fang
Journal:  Mol Pain       Date:  2021 Jan-Dec       Impact factor: 3.395

Review 10.  Sex differences in neuroimmune and glial mechanisms of pain.

Authors:  Ann M Gregus; Ian S Levine; Kelly A Eddinger; Tony L Yaksh; Matthew W Buczynski
Journal:  Pain       Date:  2021-08-01       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.